Ad is loading...
RERAX
Price
$53.01
Change
-$0.52 (-0.97%)
Updated
Nov 15 closing price
TINFX
Price
$26.03
Change
-$0.41 (-1.55%)
Updated
Nov 15 closing price
Ad is loading...

RERAX vs TINFX

Header iconRERAX vs TINFX Comparison
Open Charts RERAX vs TINFXBanner chart's image
American Funds Europacific Growth R1
Price$53.01
Change-$0.52 (-0.97%)
VolumeN/A
CapitalizationN/A
Thornburg International Growth R5
Price$26.03
Change-$0.41 (-1.55%)
VolumeN/A
CapitalizationN/A
RERAX vs TINFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RERAX vs. TINFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RERAX is a Buy and TINFX is a Buy.

FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 129B vs. TINFX (799M). RERAX pays higher dividends than TINFX: RERAX (0.91) vs TINFX (0.49). RERAX was incepted earlier than TINFX: RERAX (22 years) vs TINFX (17 years). TINFX is a more actively managed with annual turnover of: 63.54 vs. RERAX (34.00). TINFX has a lower initial minimum investment than RERAX: TINFX (0) vs RERAX (250). TINFX annual gain was more profitable for investors over the last year : 11.04 vs. RERAX (7.63). TINFX return over 5 years is better than : 14.49 vs. RERAX (3.85).
RERAXTINFXRERAX / TINFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years17 years-
Gain YTD3.0523.49987%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets129B799M16,145%
Annual Yield % from dividends0.910.49188%
Returns for 1 year7.6311.0469%
Returns for 3 years-19.45-19.8698%
Returns for 5 years3.8514.4927%
Returns for 10 years15.8932.7349%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APP291.096.60
+2.32%
Applovin Corp
BBDC9.950.06
+0.61%
Barings BDC
SIF3.60N/A
N/A
SIFCO Industries
CNS100.47-0.25
-0.25%
Cohen & Steers
FATE2.02-0.06
-2.88%
Fate Therapeutics